Volume 21, Number 3—March 2015
Dispatch
Autochthonous Dengue Fever, Tokyo, Japan, 2014
Satoshi Kutsuna
, Yasuyuki Kato, Meng Ling Moi, Akira Kotaki, Masayuki Ota, Koh Shinohara, Tetsuro Kobayashi, Kei Yamamoto, Yoshihiro Fujiya, Momoko Mawatari, Tastuya Sato, Junwa Kunimatsu, Nozomi Takeshita, Kayoko Hayakawa, Shuzo Kanagawa, Tomohiko Takasaki, and Norio Ohmagari
, Yasuyuki Kato, Meng Ling Moi, Akira Kotaki, Masayuki Ota, Koh Shinohara, Tetsuro Kobayashi, Kei Yamamoto, Yoshihiro Fujiya, Momoko Mawatari, Tastuya Sato, Junwa Kunimatsu, Nozomi Takeshita, Kayoko Hayakawa, Shuzo Kanagawa, Tomohiko Takasaki, and Norio Ohmagari
Table 2
Laboratory findings for 19 patients with dengue fever, Tokyo, Japan, August 26, 2014–September 22, 2014
| Laboratory finding at first visit |
Reference range |
Patient median (interquartile range) |
| Leukocytes, cells /mm³ | 3,500-8,500 | 2,600 (2,385–3,540) |
| Hematocrit, % | M 40–50, F 35–45 | 41.8 (38.5–42.9) |
| Platelets, ×103/μL | 150–350 | 115 (79–150) |
| Aspartate transaminase, IU/L | 13–33 | 35 (22–41) |
| Alanine transaminase, IU/L | 8–42 | 20 (14–26) |
| Lactate dehydrogenase, IU/L | 119–229 | 227 (166–261) |
| C-reactive protein, mg/L | 0–0.3 | 6.1 (2.2–16.1) |
Page created: November 02, 2017
Page updated: November 02, 2017
Page reviewed: November 02, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.